The global glucuronolactone market is
expected to reach USD 436.5 million by 2024, according to a new report by Grand
View Research, Inc. Growing consumer awareness towards the use of
glucuronolactone in various food & beverage products including energy
drinks and nutrition supplements will augment industry growth over the next
eight years. Growing use of the product for manufacturing pharmaceutical drugs
and health supplement is expected to fuel industry growth over the forecast
period. The positive outlook towards sports nutrition in light of increasing
importance of active lifestyle will promote market expansion.
Food
& beverage was the prominent end-use segment and was valued at USD 155.1
million in 2015. Rising health conscious population in the urban region is
expected to fuel demand growth over the forecast period. Rising disposable
income, increasing health awareness, growing population in various countries including
the U.S., Brazil, India and China will promote market growth over the upcoming
years.
Access Research Report
of Glucuronolactone Market @ http://www.grandviewresearch.com/industry-analysis/glucuronolactone-market
Further key findings
from the report suggest
· Pharmaceutical
application will witness the fastest growth at a CAGR of 7.0% from 2014 to 2024
as a result of increasing usage of glucuronolactone based tablets and
supplements to cure arthritis, hepatocirrhosis, and hepatitis. Furthermore,
recovery of pharmaceutical industry in the U.S. is expected to drive market
growth over the forecast period.
· North
America glucuronolactone market was valued at USD 106.7 million in 2015 and
will show significant rise owing to growing demand for energy drinks and
nutritional supplements. Moreover, adoption of glucuronolactone as a supplement
is also expected to fuel demand over the forecast period.
· Asia
Pacific will witness significant growth at a CAGR of 6.6% from 2016 to 2024 in
light of the high level of glucuronolactone producers in China, India, and
Japan with a high level of exports. Moreover, abundant availability of the
product in China is expected to have a positive impact on the market over the
coming years. Growing pharmaceutical sector in China, India, Indonesia,
Malaysia Philippines, Singapore, Thailand and Vietnam will stimulate industry
expansion.
· Key
manufacturers & exporters in the global glucuronolactone industry include
Aceto Corporation, Anhui Fubore Pharmaceutical & Chemical Co., Ltd.,
Creative Compounds, LLC, Foodchem International Corporation, Hubei Yitai
Pharmaceutical Co., Ltd., Merck Millipore Corporation, and Shaoxing Marina
Biotechnology Co., Ltd.
· Merck
Millipore Corporation offers glucuronolactone produced by glucose oxidase and
used as a nutritional supplement in pharmaceutical industries.
Grand
View Research has segmented the global glucuronolactone market on the basis of
end-use and region:
Global Glucuronolactone End-Use Outlook
(Revenue, USD Million, 2013 - 2024)
·
Food
& Beverage
·
Pharmaceuticals
·
Others
Global Glucuronolactone Regional Outlook
(Revenue, USD Million, 2013 - 2024)
·
North
America
·
Europe
·
Asia
Pacific
·
Latin
America
·
MEA
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
